Patel, R A; Hutt-Fletcher, L M; Crews, F T (1993) Epstein-Barr virus infectivity of Raji and Molt 4 cells: differences in cellular membrane lipids and apparent microviscosity. Virology 195:121-31
|
Amari, J V; Brown, P R; Pivarnik, P E et al. (1992) Isolation of experimental anti-AIDS glycerophospholipids by micro-preparative reversed-phase high-performance liquid chromatography. J Chromatogr 590:153-61
|
Amari, J V; Brown, P R; Pivarnik, P E et al. (1991) High-performance liquid chromatographic analysis of 3'-azido-3'-deoxythymidine monophosphate diglyceride, an anti-HIV glycerophospholipid. J Pharm Biomed Anal 9:871-5
|
Turcotte, J G; Lin, W H; Pivarnik, P E et al. (1991) Chemical synthesis and surface activity of lung surfactant phospholipid analogs. II. Racemic N-substituted diether phosphonolipids. Biochim Biophys Acta 1084:1-12
|
Turcotte, J G; Lin, W H; Motola, N C et al. (1991) Chemical synthesis and surface activity of lung surfactant phospholipid analogs. III. Chiral N-substituted ether-amide phosphonolipids. Chem Phys Lipids 58:81-95
|
Steim, J M; Camaioni Neto, C; Sarin, P S et al. (1990) Lipid conjugates of antiretroviral agents. I. Azidothymidine-monophosphate-diglyceride: anti-HIV activity, physical properties, and interaction with plasma proteins. Biochem Biophys Res Commun 171:451-7
|
Camaioni Neto, C; Steim, J M; Sarin, P S et al. (1990) Lipid conjugates of antiretroviral agents. II. Disodium palmityl phosphonoformate: anti-HIV activity, physical properties, and interaction with plasma proteins. Biochem Biophys Res Commun 171:458-64
|
Amari, J V; Brown, P R; Grill, C M et al. (1990) Isolation and purification of lecithin by preparative high-performance liquid chromatography. J Chromatogr 517:219-28
|
Turcotte, J G; Pivarnik, P E; Shirali, S S et al. (1990) Preparative-scale high-performance liquid chromatographic separation and purification of 3'-azido-3'-deoxythymidine-5'-phosphate. J Chromatogr 499:55-61
|
Haddad, R S; Hutt-Fletcher, L M (1989) Depletion of glycoprotein gp85 from virosomes made with Epstein-Barr virus proteins abolishes their ability to fuse with virus receptor-bearing cells. J Virol 63:4998-5005
|